3 Consumer-Oriented ETFs That Defied Thursday's Bloodbath

Published 02/09/2018, 04:10 AM
Updated 10/23/2024, 11:45 AM
US500
-
DJI
-
DIA
-
SPY
-
SPY
-
DIA
-

These are no long/short, no multi-asset, no-alternative investing strategies. Instead these are simple consumer-oriented ETFs that held their head high in Thursday’s market bloodbath. The S&P 500 is now into the correction territory for the first time in two years, down more than 10% from its record reached in January (read: Low Beta ETFs to Buy as Bulls Play Hide & Seek).

The Dow Jones Industrial Average is on track for its worst weekly percentage drop since the crisis. The index lost over 1,000 points on Feb 8, marking the second-worst point decline in history. The 10-year Treasury yield is hovering around the four-year high and was closed at 2.85% on Feb 8. Concerns over trillion-dollar budget deficits, rising rates and inflationary pressures caused this massacre.

Top three ETFs like SPDR S&P 500 ETF (NYSE:SPY) (AX:SPY) , SPDR Dow Jones Industrial Average (SI:SPDR) ETF (V:DIA) and PowerShares QQQ ETF QQQ retreated about 3.7%, 4.1% and 4.2% on Feb 8.

Like always, alternative asset classes resisted the sell-offs with the likes of PowerShares Multi-Strategy Alternative ETF LALT (up 1.30%) and AGFiQ US Market Neutral Anti-Beta BTAL (up 0.75%) in the green.

Not only this, uncorrected-to-market ETFs, plain and simple consumer-focused ETFs too battled the slaughter. In fact, one ETF has extensive exposure to the health care sector as well in the sense that it focuses on obesity-related diseases like diabetes, high blood pressure, cholesterol, heart disease, stroke & sleep apnea & companies focused on weight loss programs, weight loss supplements, or plus-size apparel.

We believe as risk-off sentiments flared-up in the market, investors sought safety in sectors like consumer staples and health care. Their non-cyclical nature offered a guard to investors’ portfolio.

Below we highlight those winners:

ETF Options

PowerShares S&P Small-Cap Consumer Staples ETF PSCC

The underlying index of the fund comprises common stocks of U.S. consumer staples companies that are principally engaged in the businesses of providing consumer goods & services that have non-cyclical characteristics, including tobacco, textiles, food and beverage & non-discretionary retail and this Index is a subset of the S&P SmallCap 600 Index.

Food products (55.85%), Food & Staples Retailing (13.12%) and Household Products (13.05%) are the three segments of the fund, which charges 29 bps in fees. The fund gained about 0.8% on Feb 8.

First Trust Nasdaq Food & Beverage ETF FTXG

The underlying index is a modified factor weighted index, designed to provide exposure to US companies within the food and beverage industry. The product charges 60 bps in fees. Food products account for about 64.7% of the fund followed by 25.4% in soft drinks and 6% in distillers and vintners. The fund advanced about 0.7% on Feb 8.

Obesity ETF SLIM

The underlying index – the Solactive Obesity Index – tracks the performance of companies globally positioned to profit from servicing the obese, including biotechnology, pharmaceutical, health care & medical device companies focusing on obesity-related diseases (read: Strong Holiday Retail Sales: 3 ETF & Stock Picks).

Health Care (81.7%), Consumer Discretionary (9.81%) and Consumer Staples (8.6%) are the top three sectors of the fund. It was up 1.2% on Feb 8.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



SPDR-DJ IND AVG (DIA): ETF Research Reports

NASDAQ-100 SHRS (QQQ): ETF Research Reports

SPDR-SP 500 TR (SPY): ETF Research Reports

QS-US MN AN-BET (BTAL): ETF Research Reports

PWRSH-SP SC C S (PSCC): ETF Research Reports

PWRSH-MS AP (LALT): ETF Research Reports

FT-NDQ FD&BVG (FTXG): ETF Research Reports

OBESITY ETF (SLIM): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.